[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100542685":3},{"organization":4,"armGroups":7,"interventions":14,"overallOfficials":20,"centralContacts":27,"locations":33,"responsibleParty":50,"collaborators":19,"id":53,"slug":19,"hasResults":54,"nctId":55,"briefTitle":56,"officialTitle":56,"acronym":57,"eligibilityCriteria":58,"healthyVolunteers":59,"sex":60,"minAge":61,"maxAge":62,"enrollmentInfo":63,"targetDuration":19,"studyType":66,"phases":67,"briefSummary":69,"conditions":70,"keywords":73,"overallStatus":36,"whyStopped":19,"lastUpdateSubmitDate":76,"lastUpdatePostDateStruct":77,"startDateStruct":80,"completionDateStruct":82,"leadSponsor":84,"locationsCount":85},{"fullName":5,"class":6},"KU Leuven","OTHER",[8],{"label":9,"type":10,"description":11,"interventionNames":12},"Survey participants","EXPERIMENTAL","Participants who will complete a survey investigating their preference for diagnosis and assessment of gastro-esophageal cancer",[13],"Other: Survey",[15],{"type":6,"name":16,"description":17,"armGroupLabels":18,"otherNames":19},"Survey","Discrete choice survey",[9],null,[21,25],{"name":22,"affiliation":23,"role":24},"Stijn Vanstraelen, MD","UZ Leuven","PRINCIPAL_INVESTIGATOR",{"name":26,"affiliation":23,"role":24},"Philippe Nafteux, MD, PhD",[28],{"name":22,"role":29,"phone":30,"phoneExt":31,"email":32},"CONTACT","16346822","0032","stijn.vanstraelen@kuleuven.be",[34],{"facility":35,"status":36,"city":37,"state":19,"zip":38,"country":39,"countryCode":40,"cosmosGeoPoint":41,"geoPoint":46,"contacts":47},"University Hospitals Leuven","RECRUITING","Leuven","3000","Belgium","BE",{"type":42,"coordinates":43},"Point",[44,45],4.70093,50.87959,{"lat":45,"lon":44},[48],{"name":22,"role":29,"phone":49,"phoneExt":31,"email":32},"16347863",{"type":24,"investigatorFullName":51,"investigatorTitle":52,"investigatorAffiliation":5,"oldNameTitle":19,"oldOrganization":19},"Stijn Vanstraelen","Principal investigator","100542685",false,"NCT06346080","Molecular Analysis for Gastro-Esophageal Cancer: Multicenter Discrete Choice Experiment","MAGECmultiDiCE","Inclusion Criteria:\n\n1. Individuals \\>18yo to 75yo (upper age limit of Barrett's surveillance)\n2. Access to computer or smartphone\n3. Clear understanding of available languages of the experiment (English, French, Dutch, Spanish, German, Chinese, Japanese)\n\nExclusion Criteria:\n\n1. Individuals less than 18yo and more than 75yo\n2. Incarcerated individuals",true,"ALL","18 Years","85 Years",{"count":64,"type":65},2200,"ESTIMATED","INTERVENTIONAL",[68],"NA","The goal of this survey is to investigate the participants' preference for a specific screening\u002Fdiagnostic tool to detect and assess gastro-esophageal cancer.\n\nThe main question it aims to answer are:\n\n* Which diagnostic modality is preferred by patients and the general population?\n* Which features of the diagnostic test are most detrimental in the decision-making for one or the other modality?\n* Are geographical differences present in regard to the preference for a diagnostic modality?\n\nParticipants will be asked to complete a survey of 20-25min, including a brief intake regarding their socio-economic status. This approach will allow us to correct for confounding factors.",[71,72],"Esophageal Cancer","Gastric Cancer",[74,16,75],"Esophageal cancer","Gastric cancer","2026-02-14",{"date":78,"type":79},"2026-02-18","ACTUAL",{"date":81,"type":79},"2024-08-01",{"date":83,"type":65},"2026-08-01",{"name":5,"class":6},1]